BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17229182)

  • 1. Role of postprandial hyperglycaemia in cardiovascular disease in diabetes.
    Yamagishi SI; Nakamura K; Matsui T; Ueda SI; Imaizumi T
    Int J Clin Pract; 2007 Jan; 61(1):83-7. PubMed ID: 17229182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease in recent onset diabetes mellitus.
    Yamagishi S
    J Cardiol; 2011 May; 57(3):257-62. PubMed ID: 21367583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What does postprandial hyperglycaemia mean?
    Heine RJ; Balkau B; Ceriello A; Del Prato S; Horton ES; Taskinen MR
    Diabet Med; 2004 Mar; 21(3):208-13. PubMed ID: 15008828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
    Bonora E
    Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The post-prandial state and macrovascular disease: relevance to diabetes mellitus.
    Shah SN; Joshi SR
    J Assoc Physicians India; 2001 Jan; 49 Spec No():32, 37-41. PubMed ID: 11235603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications.
    Monnier L; Colette C
    Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S9-6S15. PubMed ID: 26774019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.
    Monnier L; Colette C; Owens DR
    Diabetes Metab Res Rev; 2009 Jul; 25(5):393-402. PubMed ID: 19437415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood glucose control in type 2 diabetes. Basic requirements for reducing vascular complications].
    Seissler J
    Internist (Berl); 2007 Jul; 48(7):676, 678-80, 682 passim. PubMed ID: 17541528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial hyperglycaemia--its importance and implications.
    Lüddeke HJ
    Int J Clin Pract Suppl; 1999 Jul; 104():3-7; discussion 18-20. PubMed ID: 12669731
    [No Abstract]   [Full Text] [Related]  

  • 11. Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk.
    Aryangat AV; Gerich JE
    Vasc Health Risk Manag; 2010 Mar; 6():145-55. PubMed ID: 20448799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial glycaemic excursions and cardiovascular risk.
    Pradeepa R; Mohan V
    J Indian Med Assoc; 2011 Dec; 109(12):912, 917-20. PubMed ID: 23469575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial glucose - a potential therapeutic target to reduce cardiovascular mortality.
    Peter R; Okoseime OE; Rees A; Owens DR
    Curr Vasc Pharmacol; 2009 Jan; 7(1):68-74. PubMed ID: 19149642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial hyperglycaemia: noxious effects on the vessel wall.
    Hanefeld M
    Int J Clin Pract Suppl; 2002 Jul; (129):45-50. PubMed ID: 12166606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which patients should be evaluated for blood glucose variability?
    Candido R
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():9-12. PubMed ID: 24034514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
    Giugliano D; Ceriello A; Razzoli E; Esposito K
    Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial glycemia and cardiovascular disease in diabetes mellitus.
    Wajchenberg BL
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):212-21. PubMed ID: 17505628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention.
    Yamagishi S; Nakamura K; Takeuchi M; Imaizumi T
    Int J Clin Pharmacol Res; 2004; 24(4):129-34. PubMed ID: 15754918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicians can help their patients control postprandial hyperglycemia as a means of reducing cardiovascular risk.
    Gerich JE
    Diabetes Educ; 2006; 32(4):513-4, 520-2. PubMed ID: 16873589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.